MAC Hotels Limited has successfully concluded its separate board meeting of independent directors held on March 23, 2026, completing a key governance milestone for the Goa-based hospitality company. The meeting was conducted in compliance with regulatory requirements and concluded with comprehensive performance evaluations.

Meeting Execution and Timeline

The separate board meeting was held pursuant to Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 173 and Schedule IV of the Companies Act, 2013. The meeting took place at the company's registered office located at First Floor Beach Plaza (Annexee) Nomxin Caranzalem, Ilhas Goa Panaji.

Agenda Items Completed

The independent directors successfully deliberated on several critical governance matters during the 40-minute meeting. The comprehensive agenda covered key performance evaluation areas as mandated by regulatory frameworks.

Completed agenda items included:

• Review of performance of non-independent directors and the board as a whole
• Assessment of the chairperson's performance, incorporating feedback from executive and non-executive directors
• Evaluation of quality, quantity, and timeliness of information flow between company management and the board

Regulatory Compliance and Documentation

The meeting outcome was formally communicated to BSE Limited under Regulation 30, with the notification signed by Ephrem Frederick Mendanha, Independent Director (DIN: 07787277). The company maintained full compliance with disclosure obligations and regulatory requirements.

Corporate Governance Achievement

The successful completion of the separate meeting of independent directors reinforces MAC Hotels Limited's commitment to corporate governance excellence. This regulatory requirement ensures independent oversight of board performance and management effectiveness, maintaining transparency and accountability in corporate decision-making processes.

MAC Hotels Limited, incorporated in 1990 and based in Goa, continues to demonstrate adherence to evolving regulatory frameworks in the hospitality sector through structured governance practices.

MAC Hotels Limited's board of directors has approved an ambitious fundraising and expansion strategy during its meeting held on February 19, 2026. The comprehensive plan includes preferential allotment of securities worth Rs 54.76 crore and strategic diversification into the chemical industry through an acquisition.

Preferential Issue Details

The board approved the issuance of securities through preferential allotment to 65 identified investors, comprising both promoters and non-promoter entities. The fundraising structure includes two components with specific pricing and conversion terms.

For the convertible warrants, investors must pay 25% of the issue price (Rs 11.25 per warrant) upfront, totaling Rs 8,28,98,010, with the remaining 75% (Rs 33.75) payable upon conversion.

Shareholding Pattern Changes

The preferential issue will significantly alter the company's shareholding structure upon full conversion of warrants. The post-allotment scenario shows a redistribution of ownership between promoter and public categories.

Capital Structure Enhancement

To accommodate the proposed issuance, the board approved doubling the authorized share capital from Rs 9,00,00,000 to Rs 18,00,00,000. This expansion involves increasing the authorized equity shares from 90,00,000 to 1,80,00,000 shares of Rs 10 each, requiring consequential amendments to the company's Memorandum of Association.

Strategic Acquisition Initiative

The board granted provisional approval for acquiring approximately 25% stake in Herald Technocraft Private Limited (HTPL), a chemical industry company incorporated on August 23, 2020. This acquisition represents MAC Hotels' strategic diversification beyond its traditional hospitality business.

HTTP's financial performance shows significant growth, with turnover increasing from Rs 849.71 thousand in 2024 to Rs 11,305.84 thousand in 2025, while 2023 recorded zero turnover.

Business Diversification Strategy

Alongside the acquisition, the board approved expanding the company's main business objects to include chemical industry operations. The proposed addition encompasses manufacturing, trading, importing, exporting, and dealing in various chemical products including:

• Diamonds, chemicals, and chemical compounds (organic and inorganic)
• Heavy chemicals, oils, gases, and mineral products
• Agricultural and horticultural chemicals, fertilizers
• Pharmaceutical chemicals, APIs, and intermediates
• Dyestuffs, pigments, solvents, and coating materials
• Bio-chemicals and specialized chemical formulations

Regulatory Approvals and Timeline

The board has scheduled an Extraordinary General Meeting for March 21, 2026, at 12:15 p.m. (IST) to seek shareholder approval for all proposed resolutions. The preferential issue and other proposals remain subject to regulatory approvals from SEBI and other applicable authorities, along with compliance with the Companies Act, 2013, and SEBI regulations.

The board meeting, chaired by Managing Director Edgar M R Cotta, commenced at 7:00 p.m. and concluded at 8:10 p.m. on February 19, 2026, marking a significant milestone in the company's expansion strategy.